The WACC of Faron Pharmaceuticals Oy (FARN.L) is 9.2%.
| Range | Selected | |
| Cost of equity | 7.70% - 11.20% | 9.45% |
| Tax rate | -% - 0.10% | 0.05% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.5% - 10.9% | 9.2% |
| Category | Low | High |
| Long-term bond rate | 4.0% | 4.5% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.62 | 0.89 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.70% | 11.20% |
| Tax rate | -% | 0.10% |
| Debt/Equity ratio | 0.06 | 0.06 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.5% | 10.9% |
| Selected WACC | 9.2% | |